Omega-3 Index: Lab "Normal" vs Functional Optimal Explained
What the test measures
EPA is eicosapentaenoic acid and DHA is docosahexaenoic acid. The Omega-3 Index expresses their combined amount relative to the total fatty acids measured in red blood cells. A result of 6%, for example, means EPA and DHA together account for 6% of that measured fatty-acid pool. It does not mean that 6% of your diet is fish oil. [1]
The specimen and method matter. A red blood cell index is different from a plasma omega-3 concentration, and it is different from a triglyceride test. Before comparing two results, check that they measure the same thing with a comparable method.
Where “normal” and “optimal” come from
There is no single “normal above 4%” rule shared by every laboratory. The report may show a reference interval, a risk category, or a target selected by that laboratory. Those terms answer different questions.
Harris and von Schacky proposed the Omega-3 Index in 2004 as a marker related to death from coronary heart disease. In their framework, values at or below 4% were associated with the least protection and values at or above 8% with the greatest protection in the research they evaluated. Those were risk associations, not proof that prescribing enough fish oil to cross 8% prevents an event in every person. [1]
OmegaQuant, one laboratory offering the test, uses a target of 8% to 12% in its patient report. That is the laboratory's interpretation, which should be identified as such when discussing the result. [2]
| Term on a report | How to read it |
|---|---|
| Reference interval | The comparison range used by that laboratory and method |
| Risk band | A category based on a relationship observed in research |
| Target or “optimal” range | A proposed goal that needs to be considered alongside your health history |
| Your measured percentage | The actual result to compare over time using a consistent method |
The phrase “functional optimal” is not the name of a different laboratory measurement. Ask which source supports the proposed target and what action would change if you reached it.
How to interpret a result in practice
Around 4% or lower: Review habitual intake of EPA and DHA and the reason the test was ordered. This number is a prompt for a nutrition and risk discussion, not an emergency or a diagnosis of blocked arteries.
Between 4% and 8%: A result in this range sits between the commonly cited research thresholds. Whether to change intake depends on your diet, current supplements, goals, and broader cardiovascular assessment.
Around 8% to 12%: This fits OmegaQuant's stated target range. It does not cancel the risks from elevated LDL cholesterol, smoking, high blood pressure, or diabetes.
Above the laboratory's target: Review how much EPA and DHA you consume, including prescriptions and duplicate supplements. Do not assume that progressively higher values always produce greater benefit, and do not stop a prescribed medicine based on the index alone. [1,2]
For example, two people can each have an index of 6% while having very different treatment needs. One may have no cardiovascular disease and want to improve food choices; the other may have established coronary disease and elevated triglycerides despite statin treatment. The same index does not make their treatment plans interchangeable.
A test target is different from a treatment trial
Trials of omega-3 products test a particular preparation, dose, and population. They should not be summarized as though all fish oil has the same cardiovascular effect.
| Trial | Treatment and population | Finding |
|---|---|---|
| ORIGIN | A daily 1-g capsule containing at least 900 mg of omega-3 ethyl esters; 12,536 adults with dysglycemia and high cardiovascular risk | The supplement did not significantly reduce the trial's primary outcome of cardiovascular death. [3] |
| REDUCE-IT | Prescription icosapent ethyl, 2 g twice daily; 8,179 statin-treated patients with elevated triglycerides and cardiovascular disease or diabetes plus risk factors | Over a median 4.9 years, the primary cardiovascular composite occurred in 17.2% with treatment and 22.0% with placebo. [4] |
Neither trial assigned treatment by asking participants to reach an Omega-3 Index of 8%. REDUCE-IT supports a specific prescription treatment in its studied population, not substitution with any over-the-counter fish oil product.
Safety also belongs in the decision. In REDUCE-IT, hospitalization for atrial fibrillation or flutter occurred in 3.1% with icosapent ethyl versus 2.1% with placebo. Discuss high-dose omega-3 use with the prescriber, especially if you have a history of an irregular heart rhythm or take anticoagulants. [4]
What changes the index?
Regular intake of EPA and DHA can change the result over time. Sources include oily fish and products containing fish-derived or algae-derived EPA and DHA. ALA, found in foods such as flaxseed and walnuts, is another omega-3 fatty acid; the body converts only a limited amount to EPA and DHA. [5]
For food choices, the American Heart Association recommends two servings of fish per week, especially fatty fish. This is a dietary recommendation, not a requirement to buy a laboratory test first. [6]
If you use a supplement, read the EPA and DHA amounts, not just the total weight of fish oil. A capsule labeled “1,000 mg fish oil” does not necessarily contain 1,000 mg of EPA plus DHA. [5]
An illustrative label might list 180 mg EPA and 120 mg DHA per capsule. Together that is 300 mg EPA plus DHA; two capsules would supply 600 mg. Check your own label because formulations differ. This calculation explains the label, not the dose you should take.
Testing and retesting
OmegaQuant's instructions say fasting is not required for its Omega-3 Index test and that you should not change your usual omega-3 supplementation immediately before sampling. If other tests are being drawn at the same visit, follow the instructions for those tests as well. [7]
After a sustained dietary or supplement change, OmegaQuant recommends retesting after roughly three to four months. Rechecking every few days does not show the longer-term response the test is intended to track. [8]
For a useful comparison, record:
- The laboratory and test name.
- The result, units, and stated range.
- Your usual fish intake and any EPA/DHA products.
- The daily amount and the date of a dose change.
- Whether the result would change an agreed treatment or nutrition decision.
Pregnancy and other situations
Pregnancy
Use prenatal nutrition guidance with your obstetric team rather than borrowing a cardiovascular target. FDA and EPA advise people who are pregnant or breastfeeding to eat 8 to 12 ounces per week of a variety of lower-mercury fish. If you do not eat fish, discuss how to meet your nutritional needs. [9]
A 2024 study of 30 pregnancies examined maternal, placental, and fetal DHA status in relation to supplementation and maternal BMI. It found different responses by BMI group. It did not establish a universal Omega-3 Index cutoff for all pregnancies. [10]
Elevated triglycerides or established cardiovascular disease
Discuss treatment using your lipid results, cardiovascular history, and current medicines. The index is not a substitute for a triglyceride measurement or an indication to replace a statin with fish oil.
Anticoagulants or upcoming surgery
Give the care team the full supplement list and daily amounts. Ask for instructions for each product. Do not stop an anticoagulant or a prescription omega-3 medicine on your own because of an index result.
Frequently asked questions
Is an index of 5% normal?
Check the wording on your specific report. Five percent is between the commonly cited 4% and 8% research thresholds, but a laboratory may use its own categories. Interpret it with your intake and overall cardiovascular risk.
Should everyone aim for at least 8%?
Eight percent comes from the proposed research framework, and some laboratories use it as the lower end of a target. It is not a stand-alone instruction to start high-dose supplements. Clarify the goal and treatment implications with the ordering clinician. [1,2]
Does a higher index prove that fish oil is protecting my heart?
It shows omega-3 status measured by that test. The health effect of a treatment depends on the product, dose, population, and outcomes studied. [3,4]
Can I raise the index on a plant-based diet?
Algal products can supply DHA and, in some formulations, EPA. Check the label for the actual amounts and discuss the choice in the context of your diet. [5]
Must I have this test before eating more fish?
No. General dietary recommendations do not require an Omega-3 Index result. Before paying for testing, ask what decision the result would help you make. [6]
References
- Harris and von Schacky. The Omega-3 Index: a proposed coronary mortality risk factor, 2004.
- OmegaQuant: Omega-3 Index sample report, 2025.
- ORIGIN Trial Investigators. Omega-3 fatty acids and cardiovascular outcomes in dysglycemia, 2012.
- Bhatt et al. REDUCE-IT: cardiovascular risk reduction with icosapent ethyl, 2019.
- NIH Office of Dietary Supplements: Omega-3 Fatty Acids.
- American Heart Association: Seafood and cardiovascular disease.
- OmegaQuant: Testing instructions and frequently asked questions.
- OmegaQuant: Interpreting Omega-3 Index results and retesting.
- FDA and EPA: Questions and answers about eating fish during pregnancy and breastfeeding.
- Nguyen et al. Maternal DHA supplementation and maternal, fetal, and placental DHA, 2024.